Quantitation of escitalopram and its metabolites by liquid chromatography‐tandem mass spectrometry in psychiatric patients: New metabolic ratio establishment-Reference-Cited by-同舟云学术

Quantitation of escitalopram and its metabolites by liquid chromatography‐tandem mass spectrometry in psychiatric patients: New metabolic ratio establishment

Published:2018-10-17 Issue:3 Volume:124 Page:285-297
ISSN:1742-7835
Container-title:Basic & Clinical Pharmacology & Toxicology
language:en
Short-container-title:Basic Clin Pharmacol Toxicol

Author:

Canbolat Fadime¹,Tasdemir Erinç Dilek Meltem²,Evrensel Alper²,Aydın Ahmet³,Tarhan Kaşif Nevzat²

Affiliation:

1. Clinical Pharmacogenetic Laboratory NP Brain Hospital Üsküdar University Istanbul Turkey

2. NP Brain Hospital Üsküdar University Istanbul Turkey

3. Department of Toxicology Faculty of Pharmacy Yeditepe University Istanbul Turkey

Publisher

Wiley

Subject

Pharmacology,Toxicology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bcpt.13133

Reference37 articles.

1. Impact of CYP2C19 phenotypes on escitalopram metabolism and an evaluation of pupillometry as a serotonergic biomarker

2. Enantiomers' potential in psychopharmacology—a critical analysis with special emphasis on the antidepressant escitalopram

3. The Clinical Pharmacokinetics of Escitalopram

4. Enantioselective Analysis of Citalopram and Escitalopram in Postmortem Blood Together with Genotyping for CYP2D6 and CYP2C19

5. The Pharmacokinetics of Escitalopram After Oral and Intravenous Administration of Single and Multiple Doses to Healthy Subjects

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Assessment of Pharmacokinetic Effects of Herbal Medicines on Escitalopram;Therapeutics and Clinical Risk Management;2024-02

2. Straightforward paper sensors for the detection of SSRI drugs using tyrosine functionalized GQDs: Fluorescence ‘turn-off’ turns on the crucial dosage monitoring;Diamond and Related Materials;2023-11

3. Neurobiological Perspective and Personalized Treatment in Schizophrenia;Schizophrenia - Recent Advances and Patient-Centered Treatment Perspectives;2023-01-11

4. Development and validation of UHPLC-MS/MS method for simultaneous quantification of escitalopram and its major metabolites in human plasma and its application in depressed patients;Journal of Pharmaceutical and Biomedical Analysis;2022-08

5. Recent advances in liquid chromatographic methods for the determination of selective serotonin reuptake inhibitors and serotonin norepinephrine reuptake inhibitors;Biomedical Chromatography;2020-01-06